Investors in Health Diagnostics

Abingworth is a distinguished international investment firm specializing in the life sciences and healthcare sectors. Founded in 1973, we have a long-standing reputation for supporting innovative companies at various stages of development, from early-stage startups to late-stage growth enterprises. Our investment portfolio spans biotechnology, pharmaceuticals, medical devices, and healthcare services, reflecting our commitment to advancing cutting-edge technologies and treatments. With our team of seasoned professionals bringing deep industry knowledge and extensive experience, we provide strategic guidance and operational support to our portfolio companies. Our global presence, with offices in London, Menlo Park, and Boston, allows us to identify and invest in promising opportunities worldwide. Dedicated to fostering innovation and improving patient outcomes, we have successfully supported numerous companies in achieving significant milestones, demonstrating our ability to add value and drive growth.

We provide comprehensive support to (starting, growing) companies with a technological or marketing background. We work together on reaching growth targets and provide an infrastructure of knowledge and support where the management can tip into. This includes marketing, Financial, legal and human resource support.

Fielmann Ventures invests in startups worldwide (Seed – Series B) providing innovative products and digital solutions in the areas of vision and hearing with strategic relevance for the Fielmann Group, a leading optical retailer in Europe. We shape the future of vision and hearing by anticipating developments, creating strategies, and enabling solutions. Fielmann Ventures is at the heart of Fielmann’s vision to digitise the eyewear industry to the benefit of consumers without compromising quality.

Stonehaven Incubate looks at disruptive technologies in human health and identifies the unique opportunities for animals. So we shake hands with the innovators and build strategies for new, stand-alone animal health companies. We find experienced management teams. We source the capital required. In fact, we leave no stone unturned in our quest to bring human innovations to animal health.

Harbr is an accelerator and venture builder for health technology businesses. Harbr is a startup accelerator. We support founders to raise investment, build successful businesses and scale into new markets. We also serve funds - providing access to dealflow, expertise and due diligence.

Vision Health Pioneers Incubator' is a healthcare Startup program based in Berlin connecting and educating healthcare innovators in Europe. We support tech entrepreneurs with workshops, access to technology and business opportunities. We are funded by the Berlin Senate and the European Social Fund (ESF) and managed by Startup Colors UG.

LSI is a pre-seed and seed stage venture capital in Poland. We invest in early-stage start ups in life science domain. LSI is a Venture Capital Fund focused on polish life science startups in pre-seed and seed stages. We currently have 11 start-ups in our portfolio. We have startups in the field of medtech, digital health, biotech, environment protection.

NLC is the European healthtech venture builder, bringing science-based healthtech inventions to life. NLC Health Ventures - is dedicated to advancing health, making it accessible for everyone. By using entrepreneurship at scale, our unique NLC approach allows us to find inventions, and create and support ventures that have the potential to reach the patient. Led by winning teams, together with a dedicated network and driven by data and learnings.

LBBW VC founded in 1998 as an independent subsidiary of the Landesbank Baden-Wuerttenberg, LBBW Venture invests in early and late growth stages of companies. Apart from long term financial support for its portfolio companies, the team offers special commercial support by active introductions to LBBW’s fast corporate client network, pitch sessions with potential commercial clients or direct applications within the bank itself. They have a broad successful international investment track record and growth support experience given their investments in over 60 companies.

Founded in August 2015, Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals. Our primary focus is to identify and invest in emerging companies in the digital health space, globally, that could enhance Hikma’s value proposition, reputation and market intelligence. We will also consider investments in other healthcare related areas of current or future strategic interest to Hikma, including drug delivery technologies that have the potential to enhance Hikma's value chain and pipeline.

Cross Ocean Ventures is the premier early-stage investor for ambitious high-growth technology companies that got their start in Europe and Israel. - That now plan to launch or expand their footprint in the US market. - And are currently on a feasible growth path to receive US Venture Capital led Series-A funding within the next 12-24 months.

Cube Labs, the venture builder in the healthcare technology space in Italy. We are venture builders enabling innovation in the healthcare technology space. We build companies from promising early-stage R&D, and provide entrepreneurial and operational support at all the stages of their life cycle to transform pioneering science into healthcare solutions.